• Home
  • About Us
  • Contact
  • Subscribe
  • Your Account
  • Login
No Result
View All Result
Tuesday, June 6, 2023
Alternatives Watch
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
No Result
View All Result
Alternatives Watch
No Result
View All Result

Optima launches healthcare/biotech strategy

Susan BarretobySusan Barreto
January 16, 2020
in Hedge Funds, Investor News, Mandates, Open Access
ShareTweetShareSendSend

Multi-manager specialist Optima Asset Management has launched the Optima Healthcare and Biotechnology strategy, in association with the Forbes Family Trust.

D. Dixon Boardman, CEO of Optima Asset Management and vice-chairman of the Forbes Family Trust (provided)

The launch comes at a time when biotech-oriented hedge funds have performed strongly in the long/short equity space.

The new strategy will be managed by five portfolio managers with extensive experience investing in healthcare and biotech stocks. As a group these portfolio managers have generated returns greater than the S&P 500 broadly over the last decade, according to an Optima release.

“U.S. healthcare generally, and the biotech and therapeutics sub-sectors in particular, are among the most dynamic and innovative segments of the U.S. and global economies,” said D. Dixon Boardman, CEO of Optima Asset Management and vice-chairman of the Forbes Family Trust.

He added that the growth of the sector is exception even as valuations are still reasonable for many stocks. Optima’s research and due diligence has led them to identify managers whose knowledge of the sector has allowed them to add significant value.

Although several of the managers they are investing with are closed to new investors, Optima was able to gain capacity with them.

ShareTweetShareSendSend
Previous Post

European l/s equity firm Zadig joins iM Global Partner platform

Next Post

HarbourVest closes latest fund well above target

Related Posts

CDPQ hires in NYC, taps brakes on China investments
Pensions

CDPQ hires in NYC, taps brakes on China investments

People moves in the alternative investments industry
Consultants

People moves for week of June 2

Activist investor Jana Partners escalates Freshpet battle with court filing
Hedge Funds

Activist investor Jana Partners escalates Freshpet battle with court filing

Rockhampton shuts pan-Asia fund
Hedge Funds

Rockhampton shuts pan-Asia fund

Millennium hires ex-Balyasny analyst Starikovsky as senior PM
Hedge Funds

Millennium hires ex-Balyasny analyst Starikovsky as senior PM

Next Post
HarbourVest closes latest fund well above target

HarbourVest closes latest fund well above target

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Private equity mega-deals shine

Private equity mega-deals shine

HPS attracts $10bn for senior lending

HPS attracts $10bn for senior lending

Music Beats Cancer supports early stage biotechs, plans NYC benefit concert

Music Beats Cancer supports early stage biotechs, plans NYC benefit concert

CDPQ hires in NYC, taps brakes on China investments

CDPQ hires in NYC, taps brakes on China investments

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Investor News
  • Private Equity
  • Private Credit
  • Hedge Funds
  • Real Estate/Infrastructure
  • Subscribe
  • Your Membership
  • Terms of Service
  • Privacy Policy

Follow Us

No Result
View All Result
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

This Website Uses Cookies
We use cookies on our website to provide necessary functions. By clicking “Accept”, you consent to the use of all strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo